Quality of life is an important factor in the balance sheet indicator in patients with pancreatic cancer Multicenter prospective study
Original articleGastroent Hepatol 2012; 66(4): 303-310.
Summarypdf Miroslav Ryska, Ladislav Dušek, Radek Pohnán, Bohuš Bunganič, Lucie Bieberová, Ondřej Ryska, Martin Loveček, Bohumil Jon, Karel Ruppert, M. Krejčí, Jiří JarkovskýEpidemiology, hospitalization and migration of patients with IBD under specialized care in the Czech Republic
Original articleGastroent Hepatol 2017; 71(6): 501–509. doi:10.14735/amgh2017501
SummaryLiteraturepdf Jiří Jarkovský, Klára Benešová, Karel Hejduk, Ladislav Dušek, Milan LukášPart 2 – Epidemiology of inflammatory bowel diseases in the Czech population: available data sources, prevalence of treated patients and overall mortality
EditorialGastroent Hepatol 2019; 73(2): 163–166. doi:10.14735/amgh2019163
pdf Ladislav Dušek, Ondřej Ngo, Ondřej Májek, Jan Mužík, Jakub Kubát, Milan Blaha, Jiří Jarkovský, Milan LukášPart 3 – Epidemiology of idiopathic intestinal inflammations in the Czech population – time trends and statistical prediction of the number of patients
Original articleGastroent Hepatol 2019; 73(3): 257–264. doi:10.14735/amgh2019257
Literaturepdf Ladislav Dušek, Klára Benešová, Ondřej Ngo, Ondřej Májek, Jan Mužík, Jakub Kubát, Milan Blaha, Karel Hejduk, Jiří Jarkovský, Milan LukášPart 4 – Mortality and life expectancy in IBD patients
Original articleGastroent Hepatol 2019; 73(4): 345–351. doi:10.14735/amgh2019345
Literaturepdf Ladislav Dušek, Ondřej Májek, Jiří Jarkovský, Klára Benešová, Ondřej Ngo, Jan Mužík, Jakub Kubát, Milan Blaha, Karel Hejduk, Milan LukášPart 5 – Causes of death of patients with inflammatory bowel disease and related time trends
Original articleGastroent Hepatol 2019; 73(5): 438–443. doi:10.14735/amgh2019438
Literaturepdf Ladislav Dušek, Ondřej Májek, Jiří Jarkovský, Klára Benešová, Ondřej Ngo, Jan Mužík, Jakub Kubát, Milan Blaha, Karel Hejduk, Milan LukášPart 6 – Causes of death of patients with inflammatory bowel disease with a focus on hospitalization at the end of the patient’s life
Original articleGastroent Hepatol 2019; 73(6): 517–526. doi:10.14735/amgh2019517
Literaturepdf Ladislav Dušek, Ondřej Májek, Jiří Jarkovský, Klára Benešová, Ondřej Ngo, Jan Mužík, Jakub Kubát, Milan Blaha, Karel Hejduk, Milan LukášPart 7 – Time trends in the volume and proportion of diff erent types of hospitalization of patients with IBD
Original articleGastroent Hepatol 2020; 74(1): 68–75. doi:10.14735/amgh202068
pdf Ladislav Dušek, Ondřej Májek, Jiří Jarkovský, Klára Benešová, Ondřej Ngo, Jan Mužík, Jakub Kubát, Milan Blaha, Karel Hejduk, Milan LukášEffect of a synbiotic, ColonFit, in patients with irritable bowel syndrome, functional constipation and functional diarrhea
Original articleGastroent Hepatol 2020; 74(6): 535–542. doi: 10.48095/ccgh2020535
SummaryLiteraturepdf Radek Kroupa, Jiří Jarkovský, Barbora Packová, Šárka Doležalová, Hana Junková, Věra Benedíková, Jiří DolinaImpact of the COVID-19 pandemic on acute pancreatitis in the Czech Republic – pilot data PANACOTA study (PANcreatitis Acuta in COVid Time Analysis)
Original articleGastroent Hepatol 2023; 77(4): 307–314. doi: 10.48095/ccgh2023307
SummaryLiteraturepdf Martin Harazim, Radek Kroupa, Jiří Jarkovský, Ondřej Šanca, Tomáš Andrašina, Vladimír Procházka, Michal Šenkyřík